A novel photosensitizer-based photodynamic therapy reprograms the Kynurenine–AhR axis to boost antitumor immunity in breast cancer
Open Access
- 15 April 2026
- journal article
- Published by Elsevier in Redox Biology
- Vol. 93, 104171
Abstract
No abstract availableKeywords
Funding Information
- Chinese Academy of Medical Sciences Initiative for Innovative Medicine
This publication has 63 references indexed in Scilit:
- Advances in photodynamic therapy and its combination strategies for breast cancerActa Biomaterialia, 2025
- Redox regulation of cancer stem cells: Biology and therapeutic implicationsMedComm – Oncology, 2024
- Photodynamic therapy for cancer: mechanisms, photosensitizers, nanocarriers, and clinical studiesMedcomm, 2024
- Immunologic tumor microenvironment modulators for turning cold tumors hotCancer Communications, 2024
- Emerging role of metabolic reprogramming in tumor immune evasion and immunotherapyScience China Life Sciences, 2020
- Photosensitizers for Photodynamic TherapyAdvanced Healthcare Materials, 2019
- Enhancing the Efficacy of Photodynamic Therapy through a Porphyrin/POSS Alternating CopolymerAngewandte Chemie International Edition, 2018
- A fluorescent nanoprobe for real-time monitoring of intracellular singlet oxygen during photodynamic therapyMicrochimica Acta, 2018
- Anti-regulatory T cellsSeminars in Immunopathology, 2016
- Cellular uptake and photosensitizing properties of anticancer porphyrins in cell membranes and low and high density lipoproteinsJournal of Photochemistry and Photobiology B: Biology, 1990